The question of whether to write or to ‘not not’ write a letter to the secretary of state has caused a rift in the chambers.

Pfizer (PFE) closed the latest trading day at $25.23, indicating a -1.33% change from the previous session's end. The stock's change was less than the S&P 500's daily gain of 0.82%. Meanwhile, the Dow ...

Health care companies are taking a step back to better understand patients' experiences after a powerful U.S. health ...

Today, Benzinga 's options scanner spotted 29 uncommon options trades for Pfizer. This isn't normal. The overall sentiment of these big-money traders is split between 31% bullish and 62%, bearish. Out ...

On Tuesday, Pfizer Inc (PFE) stock saw a decline, ending the day at $25.57 which represents a decrease of $-0.53 or -2.03% from the prior close of $26.1. The stock opened at $26.1 and touched a low of ...

Guggenheim lowered the firm’s price target on Pfizer (PFE) to $33 from $35 and keeps a Buy rating on the shares. Pfizer will be releasing their ...

In a report released today, Umer Raffat from Evercore ISI maintained a Buy rating on Pfizer (PFE – Research Report). The company’s shares ...

Pfizer has a diversified portfolio, including successful vaccines and promising new drugs. Read more to see why I upgrade PFE ...

We recently compiled a list of the 8 Best American Dividend Stocks To Buy Right Now. In this article, we are going to take a ...

The stock's fall snapped a three-day winning streak.

Ambrosia Biosciences has moved into Pfizer's previously shuttered Boulder research and development facilities.

Eli Lilly CEO David Ricks on Tuesday said at the Economic Club of Washington that tax and regulation reform and drug ...